Risk factor
Very high price volatility
Profitability factor
Undervalued vs peers
About
ImExHS Limited delivers cloud-powered medical imaging technologies to customers worldwide, including those in Australia. The firm specializes in the development and sale of modular imaging software systems, which encompass comprehensive information management platforms for disciplines such as radiology, cardiology, and pathology, alongside a robust picture archiving and communication system (PACS). Its principal software solutions include AQUILA for radiology, ALULA for pathology, and Antero for cardiology. Moreover, ImExHS offers STELLA.I, a suite of artificial intelligence tools hosted in the cloud, crafted to bolster diagnostic capabilities for medical professionals. The company further extends outsourced radiology and teleradiology services to hospitals and various other healthcare entities. Established in 2001, ImExHS Limited operates from its base in Mascot, Australia.
Company Valuation
Considering past and projected metrics, the stock is 'cheaper' than its peers. In particular, the stock is overpriced on P/E, 'cheap' on EV/EBITDA, trading at neutral lev
Target Price
The average target price of IME.AX is 0.50 and suggests 56.2% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to in